Loading clinical trials...
Loading clinical trials...
Determination of Ka of Isolated Plasma and Whole Blood of Critically Ill Patients With Sepsis, Non-septic Patients and Healthy Volunteers: an International, In-vitro Acid-base Study.
Conditions
Interventions
In vitro determination the dissociation constant (Ka) and total amount of non-volatile buffers (Atot) in isolated plasma.
In vitro determination the dissociation constant (Ka) and total amount of non-volatile buffers (Atot) in whole blood
+1 more
Locations
2
Czechia
Third faculty of Medicine, Charles University of Prague
Prague, Czechia
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Milan, Italy
Start Date
June 3, 2019
Primary Completion Date
June 1, 2021
Completion Date
June 1, 2021
Last Updated
June 4, 2019
NCT06667999
NCT07298720
NCT07478380
NCT04850456
NCT04955210
NCT05267821
Lead Sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions